Health Care/Hospital

Koru Lifescience preparing to send drug compounds to preclinical and clinical trials based on their study for Covid-19

AUCKLAND, New Zealand, Nov. 24, 2020 /PRNewswire/ -- Koru Lifescience, drug discovery, and advanced formulation research laboratory inAuckland, New Zealand , has identified several known drug compounds of value in their study for a treatment of Covid-19. The study reports shall be published after ...

2020-11-24 04:35 943

Texas Cardiac Arrhythmia Institute at St. David's Medical Center to host virtual international symposium on complex cardiac arrhythmias

EPLive 2020, a two-day educational conference, uses live cases as primary teaching tool AUSTIN, Texas, Nov. 24, 2020 /PRNewswire/ -- On December 3 and 4, 2020, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center will host its fifth international symposium on complex arrhy...

2020-11-24 02:08 2469

Philip Wong Joins Vasayo as President of Greater China Region

PLEASANT GROVE, Utah, Nov. 24, 2020 /PRNewswire/ -- Vasayo is pleased to announcePhilip Wong as its new President of Greater China Region. Wong comes to Vasayo with more than two decades' experience driving sales as well as managing business operations and government relations for some of the mos...

2020-11-24 00:00 2578

Transforming the Future of Digital Health Management - Enjoy a More Fulfilling Life With Zepp

SHENZHEN, China, Nov. 23, 2020 /PRNewswire/ -- Zepp (pronounced /zep/), a professional brand focused on digital health management, recently hosted a live streamingevent to introduce Zepp brand, as well as launch its latest wearable, theZepp Z

2020-11-24 00:00 1773

3SBio Inc. received milestone payment of USD 4 million upon commencement of phase III clinical program of SEL-212

SHENYANG, China, Nov. 23, 2020 /PRNewswire/ -- Chinese leading biopharmaceutical company, 3SBio Inc.(01530.HK, the "Company"), announced today that Selecta Biosciences, Inc. (Nasdaq: SELB), the Company's partner, has commenced the phase III clinical program of a combination therapy involving SEL...

2020-11-23 21:28 9615

Tony Blair Institute and Oracle Launch Africa Vaccine Management in the Cloud

LONDON and REDWOOD SHORES, Calif., Nov. 23, 2020 /PRNewswire/ -- The Tony Blair Institute (TBI) and Oracle have brought cloud technology toAfrica to manage public health programs. Initially,Ghana, Rwanda, and Sierra Leone will use the newOracle Health Management System to create electronic health...

2020-11-23 21:05 4849

Manulife Singapore Gives Back to Healthcare Workers with Complimentary Passes to Manulife Sky Nets

SINGAPORE, Nov. 23, 2020 /PRNewswire/ -- Manulife Singapore will be offering each healthcare worker inSingapore up to four complimentary admission passes[1] to the Manulife Sky Nets –Walking at Jewel Changi Airport from 25 November to 25 December 2020. The month-long initiative is held in support...

2020-11-23 20:16 23315

GemVax & KAEL reports further positive data from GV1001 Phase II Alzheimer's Disease trial

SEOUL, Nov. 23, 2020 /PRNewswire/ -- GemVax & KAEL Co., Ltd. a clinical stage company developing a novel peptide drug based on telomerase modification has released further positive data at the Korean Dementia Association's Fall Conference from a Phase II trial in Alzheimer's disease of lead candi...

2020-11-23 20:00 1985

Fresenius Kabi and ASPEN partner for an expert interview series on omega-3 fatty acid containing parenteral nutrition

BAD HOMBURG, Germany, Nov. 23, 2020 /PRNewswire/ -- Evidence indicates that omega-3 (ω-3) fatty acid containing parenteral nutrition (PN) improves clinical outcomes compared with standard PN in adult patients,1 underlining its role in today's hospitals and clinics. To support continuous health ca...

2020-11-23 19:00 1580

Innovent Announces NMPA Granted New Indication Approval for SULINNO® (Adalimumab Injection) in China for the Treatment of Polyarticular Juvenile Idiopathic Arthritis

SAN FRANCISCO and SUZHOU, China, Nov. 23, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...

2020-11-23 18:34 9093

Ascentage Pharma Receives Approvals for Two Phase Ib/II Clinical Studies of the Bcl-2 Inhibitor APG-2575 for the Treatment of Waldenström Macroglobulinemia and Multiple Myeloma in China

SUZHOU, China and ROCKVILLE, Md., Nov. 23, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Center for Drug Eva...

2020-11-23 18:32 1636

Huami Corporation Reports Third Quarter 2020 Unaudited Financial Results

BEIJING, Nov. 23, 2020 /PRNewswire/ -- Huami Corporation (NYSE: HMI) today reported revenue ofRMB2.2 billion, or US$329.2 million; GAAP diluted net income per share ofRMB0.31 (US$0.05), or GAAP diluted net income per ADS of RMB1 .24 (US$0.18) for the third quarter endedSeptember 30, 2020. "Third ...

2020-11-23 17:10 8954

Zymo Research Receives CE IVD Mark for its Quick-DNA/RNA™ Viral MagBead Kit

IRVINE, Calif., Nov. 23, 2020 /PRNewswire/ -- Zymo Research announced today that itsQuick-DNA/RNA™ Viral MagBead Kit was cleared for distribution to the European Union (EU) common market. Theproduct is designed for high-throughput purification of viral DNA and/or RNA from biological samples that ...

2020-11-23 14:05 2067

Picosun's medical ALD solutions enable safer surgeries

ESPOO, Finland, Nov. 23, 2020 /PRNewswire/ -- Picosun Group, the leading supplier of AGILE ALD® (Atomic Layer Deposition) thin film coating solutions, partners with prominent Chinese hospitals and researchers to apply medical ALD technology for safer surgical procedures. Picosun's biocompatible ...

2020-11-23 10:54 1224

Rewardz Empowers Employees with Joye - A Mental Wellness & Self-Care Offering

SINGAPORE, Nov. 23, 2020 /PRNewswire/ -- According to the World Health Organisation, COVID-19 has disrupted or halted critical mental health services in 93% of countries worldwide while the demand for mental health support continues to increase. It is evident that society and businesses must reco...

2020-11-23 10:00 1795

ESMO ASIA Congress 2020 | CStone Pharmaceuticals announces the results of GEMSTONE-302, Sugemalimab has the potential to provide a new treatment option for patients with advanced NSCLC

SUZHOU, China, Nov. 23, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology (IO) therapies and precision medicines, today announced that positive clinical data based on a pre-p...

2020-11-23 09:30 3387

CGTN: China calls for more inclusive development in post-COVID world

BEIJING, Nov. 23, 2020 /PRNewswire/ -- With COVID-19 still causing widespread damage across the world,China on Saturday called for concerted efforts from major economies to promote more inclusive development and improve global governance in the post-pandemic era.   Read the ori...

2020-11-23 09:09 2160

Creation of a research partnership between Pierre Fabre and Y-Biologics for the development of new immunotherapies based on monoclonal antibodies

DAEJEON, South Korea and CASTRES, France, Nov. 23, 2020 /PRNewswire/ -- The South Korean biotech company Y-Biologics and the French pharmaceutical group Pierre Fabre have announced their plans to form a strategic partnership in the field of immuno-oncology research. The decision has been acknowle...

2020-11-23 09:00 2035

Infinitus Harnesses eCommerce to Offer Greater Direct Selling Opportunities for Partners

GUANGZHOU, China, Nov. 23, 2020 /PRNewswire/ -- Ahead of key eCommerce festivals such as 11.11 and Black Friday, Infinitus (China) Company Ltd ("Infinitus"), a purveyor of health products and solutions, has harnessed the power of social e-Commerce to open up new direct selling opportunities for ...

2020-11-23 09:00 1837

G20 Riyadh Summit: Release of Leaders' Declaration

RIYADH, Saudi Arabia, Nov. 23, 2020 /PRNewswire/ -- G20 Leaders endorsed their declaration at the end of their summit todayNovember 22, 2020, including agreements on steps to be taken to protect lives and shape a better future.  "We, the G20 Leaders, meeting for the second time under the Saudi Pr...

2020-11-23 08:30 1354
1 ... 590591592593594595596 ... 806